Analogue de GHRH pour la recherche sur la composition corporelle.
Tesamorelin is an FDA-approved GHRH analog used for the treatment of HIV-associated lipodystrophy. It has a modified structure for improved stability.
Key Research Areas:
• HIV-associated lipodystrophy (FDA approved)
• Visceral fat reduction
• Cognitive function in aging
• Metabolic syndrome
• Non-alcoholic fatty liver disease
Tesamorelin is unique among GHRH analogs for its FDA approval status and proven efficacy in reducing visceral adipose tissue.
RESEARCH USE ONLY: All products sold on this website are intended for laboratory and research purposes only. These products are NOT intended for human or animal consumption.
